Stem cells and diabetic cardiomyopathy: from pathology to therapy
Authors:
- 24 May 2016
- journal article
- review article
- Published by Springer Nature in Heart Failure Reviews
- Vol. 21 (6) , 723-736
Abstract
The worldwide increase trend in the prevalence of diabetes has highlighted the need for increased research efforts into treatment options for both the disease itself and its associated complications. Diabetes has been widely recognized as a major risk factor for cardiovascular diseases, such as coronary heart disease and hypertension. Diabetic cardiomyopathy (DCM) is a main complication of diabetes, contributing to specific forms of heart failure independent from ischemia or hypertension. Without considerably effective approaches, a dire need exists to further explore the mechanisms and potential therapeutic strategies to prevent or reverse the progression of DCM. In the past decades, stem cell-based therapies have held promises to various diseases including DCM. The aim of the present review was to summarize the current literature with regard to the pathological changes of diabetic cardiomyopathy, endogenous stem cells in diabetes, and the exogenous stem cells transplantation for DCM. If the best use is made of the advantages of stem cells and their mechanism of action is explicitly explored, stem cell-based therapies could served as an important tool for the prevention and treatment of DCM patients.Keywords
Funding Information
- National Science Foundation of China (No. 81100141, No.81570322)
- National Natural Science Foundation of China (CN) (No. 81500334)
- Natural Science Foundation of Zhejiang Province (CN) (No.Y14H020003)
- Qianjiang Talents Project of Science and Technology Bureau of Zhejiang Province (No. 2013R10032)
- Experimental Animal Science Project of Science and Technology Bureau of Zhejiang Province (No. 2015C37109)
This publication has 112 references indexed in Scilit:
- Bone Marrow Progenitor Cell Therapy-Mediated Paracrine Regulation of Cardiac miRNA-155 Modulates Fibrotic Response in Diabetic HeartsPLOS ONE, 2013
- Predictors and prevention of diabetic cardiomyopathyDiabetes, Metabolic Syndrome and Obesity, 2013
- Prediabetes: a high-risk state for diabetes developmentThe Lancet, 2012
- Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes MellitusStem Cells, 2011
- Impairment of both nitric oxide‐mediated and EDHF‐type relaxation in small mesenteric arteries from rats with streptozotocin‐induced diabetesBritish Journal of Pharmacology, 2010
- Hyperglycemia and Oxidized-LDL exert a deleterious effect on Endothelial Progenitor Cell migration in Type 2 Diabetes MellitusThrombosis Research, 2010
- Virus-free induction of pluripotency and subsequent excision of reprogramming factorsNature, 2009
- Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming FactorsCell, 2009
- Association Between Diabetes Mellitus and Left Ventricular Hypertrophy in a Multiethnic PopulationThe American Journal of Cardiology, 2008
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006